R3-v2-0292-for-R5
type: ValueSet
node role: treeRoot
id:
  v: R3-v2-0292-for-R5
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ValueSet R3-v2-0292-for-R5 This value set expansion contains 124 concepts. System Version Code Display http://hl7.org/fhir/v2/0292 2.8.2 01 DTP http://hl7.org/fhir/v2/0292 2.8.2 02 OPV http://hl7.org/fhir/v2/0292 2.8.2 03 MMR http://hl7.org/fhir/v2/0292 2.8.2 04 M/R http://hl7.org/fhir/v2/0292 2.8.2 05 measles http://hl7.org/fhir/v2/0292 2.8.2 06 rubella http://hl7.org/fhir/v2/0292 2.8.2 07 mumps http://hl7.org/fhir/v2/0292 2.8.2 08 Hep B, adolescent or pediatric http://hl7.org/fhir/v2/0292 2.8.2 09 Td (adult) http://hl7.org/fhir/v2/0292 2.8.2 10 IPV http://hl7.org/fhir/v2/0292 2.8.2 100 pneumococcal conjugate http://hl7.org/fhir/v2/0292 2.8.2 101 typhoid, ViCPs http://hl7.org/fhir/v2/0292 2.8.2 102 DTP-Hib-Hep B http://hl7.org/fhir/v2/0292 2.8.2 103 meningococcal C conjugate http://hl7.org/fhir/v2/0292 2.8.2 104 Hep A-Hep B http://hl7.org/fhir/v2/0292 2.8.2 105 vaccinia (smallpox) diluted http://hl7.org/fhir/v2/0292 2.8.2 106 DTaP, 5 pertussis antigens6 http://hl7.org/fhir/v2/0292 2.8.2 107 DTaP, NOS http://hl7.org/fhir/v2/0292 2.8.2 108 meningococcal, NOS http://hl7.org/fhir/v2/0292 2.8.2 109 pneumococcal, NOS http://hl7.org/fhir/v2/0292 2.8.2 11 pertussis http://hl7.org/fhir/v2/0292 2.8.2 110 DTaP-Hep B-IPV http://hl7.org/fhir/v2/0292 2.8.2 111 influenza, live, intranasal http://hl7.org/fhir/v2/0292 2.8.2 112 tetanus toxoid, NOS http://hl7.org/fhir/v2/0292 2.8.2 113 Td (adult) http://hl7.org/fhir/v2/0292 2.8.2 114 meningococcal A,C,Y,W-135 diphtheria conjugate http://hl7.org/fhir/v2/0292 2.8.2 115 Tdap http://hl7.org/fhir/v2/0292 2.8.2 116 rotavirus, pentavalent http://hl7.org/fhir/v2/0292 2.8.2 117 VZIG (IND) http://hl7.org/fhir/v2/0292 2.8.2 118 HPV, bivalent http://hl7.org/fhir/v2/0292 2.8.2 119 rotavirus, monovalent http://hl7.org/fhir/v2/0292 2.8.2 12 diphtheria antitoxin http://hl7.org/fhir/v2/0292 2.8.2 120 DTaP-Hib-IPV http://hl7.org/fhir/v2/0292 2.8.2 121 zoster http://hl7.org/fhir/v2/0292 2.8.2 122 rotavirus, NOS1 http://hl7.org/fhi…
extension:
  url:
    v: http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm
    l: structuredefinition-fmm
  value: Integer
    v: 0
extension:
  url:
    v: http://hl7.org/fhir/StructureDefinition/structuredefinition-wg
    l: structuredefinition-wg
  value: Code
    v: fhir
extension:
  extension:
    url:
      v: packageId
      l: packageId
    value: Id
      v: hl7.fhir.uv.xver-r3.r5
  extension:
    url:
      v: version
      l: version
    value: String
      v: 0.1.0
  extension:
    url:
      v: uri
      l: uri
    value: Uri
      v: http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r5
      l: hl7.fhir.uv.xver-r3.r5
  url:
    v: http://hl7.org/fhir/StructureDefinition/package-source
    l: package-source
extension:
  url:
    v: http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status
    l: structuredefinition-standards-status
  value: Code
    v: trial-use
    extension:
      url:
        v: http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom
        l: structuredefinition-conformance-derivedFrom
      value: Canonical
        v: http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r3.r5
        l: hl7.fhir.uv.xver-r3.r5
url:
  v: http://hl7.org/fhir/uv/xver/ValueSet/R3-v2-0292-for-R5
  l: R3-v2-0292-for-R5
version:
  v: 0.1.0
name:
  v: R3V20292ForR5
title:
  v: Cross-version ValueSet STU3.v2 Vaccines Administered (code = CVX) (parenteral, un for use in FHIR R5
status:
  v: active
experimental:
  v: false
date:
  v: 2026-03-17T21:02:03.8104715+00:00
publisher:
  v: FHIR Infrastructure
contact:
  name:
    v: FHIR Infrastructure
  telecom:
    system:
      v: url
    value:
      v: http://www.hl7.org/Special/committees/fiwg
description:
  v: This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v2-0292|2.8.2` for use in FHIR R5.
jurisdiction:
  coding:
    system:
      v: http://unstats.un.org/unsd/methods/m49/m49.htm
      l: m49.htm
    code:
      v: 001
    display:
      v: World
purpose:
  v: This value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/v2-0292|2.8.2` as defined in FHIR STU3 in FHIR R5. The source value set is bound to the following FHIR STU3 elements: * Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: FHIR ValueSet `http://hl7.org/fhir/ValueSet/v2-0292|2.8.2`, defined in FHIR STU3 does not have any mapping to FHIR R5
compose:
  include:
    system:
      v: http://hl7.org/fhir/v2/0292
      l: http://hl7.org/fhir/v2/0292
    version:
      v: 2.8.2
    concept:
      code:
        v: 01
      display:
        v: DTP
    concept:
      code:
        v: 02
      display:
        v: OPV
    concept:
      code:
        v: 03
      display:
        v: MMR
    concept:
      code:
        v: 04
      display:
        v: M/R
    concept:
      code:
        v: 05
      display:
        v: measles
    concept:
      code:
        v: 06
      display:
        v: rubella
    concept:
      code:
        v: 07
      display:
        v: mumps
    concept:
      code:
        v: 08
      display:
        v: Hep B, adolescent or pediatric
    concept:
      code:
        v: 09
      display:
        v: Td (adult)
    concept:
      code:
        v: 10
      display:
        v: IPV
    concept:
      code:
        v: 100
      display:
        v: pneumococcal conjugate
    concept:
      code:
        v: 101
      display:
        v: typhoid, ViCPs
    concept:
      code:
        v: 102
      display:
        v: DTP-Hib-Hep B
    concept:
      code:
        v: 103
      display:
        v: meningococcal C conjugate
    concept:
      code:
        v: 104
      display:
        v: Hep A-Hep B
    concept:
      code:
        v: 105
      display:
        v: vaccinia (smallpox) diluted
    concept:
      code:
        v: 106
      display:
        v: DTaP, 5 pertussis antigens6
    concept:
      code:
        v: 107
      display:
        v: DTaP, NOS
    concept:
      code:
        v: 108
      display:
        v: meningococcal, NOS
    concept:
      code:
        v: 109
      display:
        v: pneumococcal, NOS

code:
  v: 11
display:
  v: pertussis

code:
  v: 110
display:
  v: DTaP-Hep B-IPV

code:
  v: 111
display:
  v: influenza, live, intranasal

code:
  v: 112
display:
  v: tetanus toxoid, NOS

code:
  v: 113
display:
  v: Td (adult)

code:
  v: 114
display:
  v: meningococcal A,C,Y,W-135 diphtheria conjugate

code:
  v: 115
display:
  v: Tdap

code:
  v: 116
display:
  v: rotavirus, pentavalent

code:
  v: 117
display:
  v: VZIG (IND)

code:
  v: 118
display:
  v: HPV, bivalent

code:
  v: 119
display:
  v: rotavirus, monovalent

code:
  v: 12
display:
  v: diphtheria antitoxin

code:
  v: 120
display:
  v: DTaP-Hib-IPV

code:
  v: 121
display:
  v: zoster

code:
  v: 122
display:
  v: rotavirus, NOS1

code:
  v: 13
display:
  v: TIG

code:
  v: 14
display:
  v: IG, NOS

code:
  v: 15
display:
  v: influenza, split (incl. purified surface antigen)

code:
  v: 16
display:
  v: influenza, whole

code:
  v: 17
display:
  v: Hib, NOS

code:
  v: 18
display:
  v: rabies, intramuscular injection

code:
  v: 19
display:
  v: BCG

code:
  v: 20
display:
  v: DTaP

code:
  v: 21
display:
  v: varicella

code:
  v: 22
display:
  v: DTP-Hib

code:
  v: 23
display:
  v: plague

code:
  v: 24
display:
  v: anthrax

code:
  v: 25
display:
  v: typhoid, oral

code:
  v: 26
display:
  v: cholera

code:
  v: 27
display:
  v: botulinum antitoxin

code:
  v: 28
display:
  v: DT (pediatric)

code:
  v: 29
display:
  v: CMVIG

code:
  v: 30
display:
  v: HBIG

code:
  v: 31
display:
  v: Hep A, pediatric, NOS

code:
  v: 32
display:
  v: meningococcal

code:
  v: 33
display:
  v: pneumococcal

code:
  v: 34
display:
  v: RIG

code:
  v: 35
display:
  v: tetanus toxoid

code:
  v: 36
display:
  v: VZIG

code:
  v: 37
display:
  v: yellow fever

code:
  v: 38
display:
  v: rubella/mumps

code:
  v: 39
display:
  v: Japanese encephalitis

code:
  v: 40
display:
  v: rabies, intradermal injection

code:
  v: 41
display:
  v: typhoid, parenteral

code:
  v: 42
display:
  v: Hep B, adolescent/high risk infant2

code:
  v: 43
display:
  v: Hep B, adult4

code:
  v: 44
display:
  v: Hep B, dialysis

code:
  v: 45
display:
  v: Hep B, NOS

code:
  v: 46
display:
  v: Hib (PRP-D)

code:
  v: 47
display:
  v: Hib (HbOC)

code:
  v: 48
display:
  v: Hib (PRP-T)

code:
  v: 49
display:
  v: Hib (PRP-OMP)

code:
  v: 50
display:
  v: DTaP-Hib

code:
  v: 51
display:
  v: Hib-Hep B

code:
  v: 52
display:
  v: Hep A, adult

code:
  v: 53
display:
  v: typhoid, parenteral, AKD (U.S. military)

code:
  v: 54
display:
  v: adenovirus, type 4

code:
  v: 55
display:
  v: adenovirus, type 7

code:
  v: 56
display:
  v: dengue fever

code:
  v: 57
display:
  v: hantavirus

code:
  v: 58
display:
  v: Hep C

code:
  v: 59
display:
  v: Hep E

code:
  v: 60
display:
  v: herpes simplex 2

code:
  v: 61
display:
  v: HIV

code:
  v: 62
display:
  v: HPV, quadrivalent

code:
  v: 63
display:
  v: Junin virus

code:
  v: 64
display:
  v: leishmaniasis

code:
  v: 65
display:
  v: leprosy

code:
  v: 66
display:
  v: Lyme disease

code:
  v: 67
display:
  v: malaria

code:
  v: 68
display:
  v: melanoma

code:
  v: 69
display:
  v: parainfluenza-3

code:
  v: 70
display:
  v: Q fever

code:
  v: 71
display:
  v: RSV-IGIV

code:
  v: 72
display:
  v: rheumatic fever

code:
  v: 73
display:
  v: Rift Valley fever

code:
  v: 74
display:
  v: rotavirus, tetravalent

code:
  v: 75
display:
  v: vaccinia (smallpox)

code:
  v: 76
display:
  v: Staphylococcus bacterio lysate

code:
  v: 77
display:
  v: tick-borne encephalitis

code:
  v: 78
display:
  v: tularemia vaccine

code:
  v: 79
display:
  v: vaccinia immune globulin

code:
  v: 80
display:
  v: VEE, live

code:
  v: 81
display:
  v: VEE, inactivated

code:
  v: 82
display:
  v: adenovirus, NOS1

code:
  v: 83
display:
  v: Hep A, ped/adol, 2 dose

code:
  v: 84
display:
  v: Hep A, ped/adol, 3 dose

code:
  v: 85
display:
  v: Hep A, NOS

code:
  v: 86
display:
  v: IG

code:
  v: 87
display:
  v: IGIV

code:
  v: 88
display:
  v: influenza, NOS

code:
  v: 89
display:
  v: polio, NOS

code:
  v: 90
display:
  v: rabies, NOS

code:
  v: 91
display:
  v: typhoid, NOS

code:
  v: 92
display:
  v: VEE, NOS

code:
  v: 93
display:
  v: RSV-MAb

code:
  v: 94
display:
  v: MMRV

code:
  v: 95
display:
  v: TST-OT tine test

code:
  v: 96
display:
  v: TST-PPD intradermal

code:
  v: 97
display:
  v: TST-PPD tine test

code:
  v: 98
display:
  v: TST, NOS

code:
  v: 99
display:
  v: RESERVED - do not use3

code:
  v: 998
display:
  v: no vaccine administered5

code:
  v: 999
display:
  v: unknown

timestamp:
  v: 2026-03-17T21:02:03.8104715+00:00
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 01
  display:
    v: DTP
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 02
  display:
    v: OPV
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 03
  display:
    v: MMR
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 04
  display:
    v: M/R
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 05
  display:
    v: measles
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 06
  display:
    v: rubella
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 07
  display:
    v: mumps
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 08
  display:
    v: Hep B, adolescent or pediatric
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 09
  display:
    v: Td (adult)
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 10
  display:
    v: IPV
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 100
  display:
    v: pneumococcal conjugate
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 101
  display:
    v: typhoid, ViCPs
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 102
  display:
    v: DTP-Hib-Hep B
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 103
  display:
    v: meningococcal C conjugate
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 104
  display:
    v: Hep A-Hep B
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 105
  display:
    v: vaccinia (smallpox) diluted
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 106
  display:
    v: DTaP, 5 pertussis antigens6
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 107
  display:
    v: DTaP, NOS
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 108
  display:
    v: meningococcal, NOS
contains:
  system:
    v: http://hl7.org/fhir/v2/0292
    l: http://hl7.org/fhir/v2/0292
  version:
    v: 2.8.2
  code:
    v: 109
  display:
    v: pneumococcal, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 11
display:
  v: pertussis

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 110
display:
  v: DTaP-Hep B-IPV

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 111
display:
  v: influenza, live, intranasal

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 112
display:
  v: tetanus toxoid, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 113
display:
  v: Td (adult)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 114
display:
  v: meningococcal A,C,Y,W-135 diphtheria conjugate

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 115
display:
  v: Tdap

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 116
display:
  v: rotavirus, pentavalent

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 117
display:
  v: VZIG (IND)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 118
display:
  v: HPV, bivalent

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 119
display:
  v: rotavirus, monovalent

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 12
display:
  v: diphtheria antitoxin

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 120
display:
  v: DTaP-Hib-IPV

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 121
display:
  v: zoster

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 122
display:
  v: rotavirus, NOS1

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 13
display:
  v: TIG

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 14
display:
  v: IG, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 15
display:
  v: influenza, split (incl. purified surface antigen)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 16
display:
  v: influenza, whole

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 17
display:
  v: Hib, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 18
display:
  v: rabies, intramuscular injection

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 19
display:
  v: BCG

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 20
display:
  v: DTaP

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 21
display:
  v: varicella

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 22
display:
  v: DTP-Hib

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 23
display:
  v: plague

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 24
display:
  v: anthrax

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 25
display:
  v: typhoid, oral

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 26
display:
  v: cholera

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 27
display:
  v: botulinum antitoxin

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 28
display:
  v: DT (pediatric)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 29
display:
  v: CMVIG

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 30
display:
  v: HBIG

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 31
display:
  v: Hep A, pediatric, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 32
display:
  v: meningococcal

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 33
display:
  v: pneumococcal

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 34
display:
  v: RIG

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 35
display:
  v: tetanus toxoid

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 36
display:
  v: VZIG

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 37
display:
  v: yellow fever

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 38
display:
  v: rubella/mumps

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 39
display:
  v: Japanese encephalitis

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 40
display:
  v: rabies, intradermal injection

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 41
display:
  v: typhoid, parenteral

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 42
display:
  v: Hep B, adolescent/high risk infant2

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 43
display:
  v: Hep B, adult4

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 44
display:
  v: Hep B, dialysis

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 45
display:
  v: Hep B, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 46
display:
  v: Hib (PRP-D)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 47
display:
  v: Hib (HbOC)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 48
display:
  v: Hib (PRP-T)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 49
display:
  v: Hib (PRP-OMP)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 50
display:
  v: DTaP-Hib

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 51
display:
  v: Hib-Hep B

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 52
display:
  v: Hep A, adult

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 53
display:
  v: typhoid, parenteral, AKD (U.S. military)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 54
display:
  v: adenovirus, type 4

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 55
display:
  v: adenovirus, type 7

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 56
display:
  v: dengue fever

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 57
display:
  v: hantavirus

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 58
display:
  v: Hep C

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 59
display:
  v: Hep E

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 60
display:
  v: herpes simplex 2

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 61
display:
  v: HIV

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 62
display:
  v: HPV, quadrivalent

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 63
display:
  v: Junin virus

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 64
display:
  v: leishmaniasis

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 65
display:
  v: leprosy

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 66
display:
  v: Lyme disease

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 67
display:
  v: malaria

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 68
display:
  v: melanoma

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 69
display:
  v: parainfluenza-3

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 70
display:
  v: Q fever

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 71
display:
  v: RSV-IGIV

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 72
display:
  v: rheumatic fever

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 73
display:
  v: Rift Valley fever

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 74
display:
  v: rotavirus, tetravalent

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 75
display:
  v: vaccinia (smallpox)

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 76
display:
  v: Staphylococcus bacterio lysate

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 77
display:
  v: tick-borne encephalitis

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 78
display:
  v: tularemia vaccine

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 79
display:
  v: vaccinia immune globulin

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 80
display:
  v: VEE, live

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 81
display:
  v: VEE, inactivated

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 82
display:
  v: adenovirus, NOS1

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 83
display:
  v: Hep A, ped/adol, 2 dose

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 84
display:
  v: Hep A, ped/adol, 3 dose

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 85
display:
  v: Hep A, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 86
display:
  v: IG

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 87
display:
  v: IGIV

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 88
display:
  v: influenza, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 89
display:
  v: polio, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 90
display:
  v: rabies, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 91
display:
  v: typhoid, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 92
display:
  v: VEE, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 93
display:
  v: RSV-MAb

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 94
display:
  v: MMRV

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 95
display:
  v: TST-OT tine test

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 96
display:
  v: TST-PPD intradermal

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 97
display:
  v: TST-PPD tine test

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 98
display:
  v: TST, NOS

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 99
display:
  v: RESERVED - do not use3

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 998
display:
  v: no vaccine administered5

system:
  v: http://hl7.org/fhir/v2/0292
  l: http://hl7.org/fhir/v2/0292
version:
  v: 2.8.2
code:
  v: 999
display:
  v: unknown